Developmental changes in distribution patterns of phencyclidine-induced c-Fos in rat forebrain

Neuroscience Letters

Volumn 239, Issue 1, 1997, Pages 21-24

  Sato, Daisuke ^a,b   Umino, Asami ^a   Kaneda, Koyuki ^a   Takigawa, Morikuni ^b   Nishikawa, Toru ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

C Fos; Development; Immunohistochemistry; Neocortex; Phencyclidine

Indexed keywords

PHENCYCLIDINE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CONTROLLED STUDY; FOREBRAIN; MALE; NEOCORTEX; NONHUMAN; OLFACTORY BULB; ONCOGENE C FOS; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PYRIFORM CORTEX; RAT; SCHIZOPHRENIA; SEPTUM PELLUCIDUM; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANIMALS, NEWBORN; HALLUCINOGENS; IMMUNOHISTOCHEMISTRY; MALE; NERVE TISSUE PROTEINS; PHENCYCLIDINE; PROSENCEPHALON; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR;

EID: 0031565990     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00879-3     Document Type: Article

References (21)

1. Akazawa T., Shigemoto R., Bessho Y., Nakanishi S., Mizuno N. Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats. J. Comp. Neurol. 347:1994;150-160.
2. Bayer, S.A. and Altman, J., Neocortical Development, Raven Press, New York, 1991, 255 pp.
3. Detogni P., Niman H., Raymond V., Sawchenko P., Verma I.M. Detection of fos protein during osteogenesis by monoclonal antibodies. Mol. Cell. Biol. 8:1988;2251-2256.
4. Dragunow M., Faull R.L.M. MK-801 induces c-fos protein in thalamic and neocortical neurons of rat brain. Neurosci. Lett. 111:1990;39-45.
5. Graybiel A.M., Moratalla R., Robertson H. Amphetamine and cocaine induce drug-specific activation of the c-fos gene expression in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA. 87:1990;6912-6916.
6. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry. 148:1991;1301-1308.
7. Johnson K.M., Jones S.M. Neuropharmacology of phencyclidine, Ann. Rev. Pharmacol. Toxicol. 30:1990;707-750.
8. Kosofsky B.E., Genova L.M., Hyman S.E. Postnatal age defines specificity of immediate early gene induction by cocaine in developing rat brain. J. Comp. Neurol. 2:1995;27-40.
9. Morgan J.I., Curren T. Stimulus-transcription coupling in the nervous system: involvement of inducible proto-oncogenes fos and jun. Ann. Rev. Neurosci. 14:1991;421-451.
10. Näkki R., Nickolenko J., Chang J., Sagar S.M., Sharp S.R. Haloperidol prevents ketamine- and phencyclidine-induced HSP70 protein expression but not microglial activation. Exp. Neurol. 137:1996;234-241.
11. Nishikawa, T., Umino, A., Kashiwa, A., Ooshima, A., Nomura, N. and Takahashi, T., Stimulant-induced behavioral sensitization and cerebral neurotransmission. In M. Toru (Ed.), Neurotransmitters in Neuronal Plasticity and Psychiatric Disorders, Excerpta Medica, Tokyo, 1993, pp. 53-62.
12. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, New York, 1986.
13. Sakurai-Yamashita Y., Sassone-Corsi P., Gombos G. Immunohistochemistry of c-fos in mouse brain during postnatal development: basal levels and changing response to metrazol and kainate injection. Eur. J. Neurosci. 3:1991;764-770.
14. Scalzo F.M., Burge L.J. The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats. Neurotoxicology. 15:1994;191-200.
15. Scalzo F.M., Holson R.R. The ontogeny of behavioral sensitization to phencyclidine. Neurotoxicol. Teratol. 14:1992;7-14.
16. Siegel, R.K., Phencyclidine and ketamine intoxication: a study of four populations of recreational users. In R.C. Petersen and R.C. Stillman (Eds.), Phencyclidine (PCP) Abuse: An Appraisal, NIDA Research Monograph 21, US Government Printing Office, Washington, DC, 1978, pp. 119-147.
17. Subramaniam S., McGonigle P. Regional profile of developmental changes in the sensitivity of the N-methyl-D-aspartate receptor to polyamines. J. Neurochem. 62(4):1994;1408-1415.
18. Tamminga C.A., Holcomb H.H., Gao X.-M., Lahti A.C. Glutamate pharmacology and the treatment of schizophrenia: current status and future directions. Int. Clin. Psychopharmacol. 10(suppl. 3):1995;29-37.
19. Tanii Y., Nishikawa T., Hashimoto A., Takahashi K. Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in rat. J. Pharmacol. Exp. Ther. 269:1994;1040-1048.
20. Umino A., Nishikawa T., Takahashi K. Methamphetamine-induced nuclear c-Fos in rat brain regions. Neurochem. Int. 26:1995;85-90.
21. Young A.B., Fagg G.E. Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches. Trends Pharmacol. Sci. 11:1990;126-133.